graph EGM comparisons
nivolumab plus ipilimumabtitleipilimumab alonetitlenivolumab alonetitleCheckMate 069 (all population), 2015 NCT01927419 mML - L1 - all population 95/47CheckMate 067 (NI vs I ; all population), 2015 NCT01844505 mML - L1 - all population 314/315CheckMate 067 (NI vs N) EXPLORATORY, 2015 NCT01844505 mML - L1 - all population 314/316CheckMate 069 (BRAF mutant) EXPLORATORY, 2015 NCT01927419 mML - L1 - BRAF mutant 23/10CheckMate 069 (BRAF wild type), 2015 NCT01927419 mML - L1 - BRAF wild 72/37

Pathology:  mML - L1 - all population;   mML - L1 - BRAF mutant;   mML - L1 - BRAF wild; 

mML - L1 - all populationmML - L1 - BRAF mutantmML - L1 - BRAF wild
CheckMate 069 (all population), 2015CheckMate 067 (NI vs I ; all population), 2015CheckMate 067 (NI vs N) EXPLORATORY, 2015CheckMate 069 (BRAF mutant) EXPLORATORY, 2015CheckMate 069 (BRAF wild type), 2015
nivolumab plus ipilimumab5T1T1T1T1T1
ipilimumab alone0T0T0T0T0
nivolumab alone0T0